
GlobalSubmit™ REVIEW Page
Powerful but simple review of all your submissions across programs and stakeholders.
Powerful but simple review of all your submissions across programs and stakeholders.
Create health authority compliant eCTD submissions quickly and accurately.
250 Label claims using PBPK without the need for additional clinical studies “Clinical Studies and Model-Informed Approaches.” This is the language typically used by the US FDA on drug labels…
By Professor Piet van der Graaf, Ph.D., and Hugo Geerts, Ph.D. Neurodegenerative diseases (NDs) affect millions of people worldwide. In the US alone, five million people suffer from Alzheimer disease;…
• The predictive performance of physiologically based pharmacokinetic(s) (PBPK) models for PK in renal impairment (RI) and hepatic impairment (HI) populations was evaluated using clinical data from 29 compounds with…
It is crucial for biotech developers to engage in early commercial market assessment to generate value for Regulators, Payers, and Clinicians. This approach should be integrated with a clinical development…
Simplify Controlled Terminology with expert insights from Sarah Angelo. Overcome challenges, ensure compliance, and improve your submission process.
Certara’s Dr. Piet van der Graaf, Senior Vice President, Professor of Systems Pharmacology, Leiden University, and Editor-in-Chief of Clinical Pharmacology and Therapeutics presents the opening lecture for Pharmacology 2020.